Literature DB >> 24595679

Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients.

Eileen M Le1, Monica E Loghin.   

Abstract

Posterior reversible encephalopathy syndrome is a well-recognized entity associated with a variety of benign and malignant conditions. This syndrome typically manifests itself with headache, visual loss, and seizures. Radiographic abnormalities consist of white matter edema involving the posterior parietal and occipital lobes, manifested as increased T2 and fluid-attenuated inversion recovery signal intensity on magnetic resonance imaging. In the last decade, there has been a reported increase in the incidence of posterior reversible encephalopathy syndrome in cancer patients. The diagnosis can be challenging in this patient population. Early recognition and initiation of appropriate therapy with removal of the causative agent is essential in order to prevent permanent neurologic sequelae.

Entities:  

Mesh:

Year:  2014        PMID: 24595679     DOI: 10.1007/s11912-014-0383-3

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  79 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

Review 2.  Year in review in intensive care medicine, 2004. III. Outcome, ICU organisation, scoring, quality of life, ethics, psychological problems and communication in the ICU, immunity and hemodynamics during sepsis, pediatric and neonatal critical care, experimental studies.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2005-02-18       Impact factor: 17.440

Review 3.  Reversible posterior leukoencephalopathy syndrome in cancer.

Authors:  Christopher Vaughn; Louann Zhang; David Schiff
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

4.  Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.

Authors:  Jennifer E Fugate; Daniel O Claassen; Harry J Cloft; David F Kallmes; Osman S Kozak; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

5.  Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings.

Authors:  R Bakshi; V E Bates; L L Mechtler; P R Kinkel; W R Kinkel
Journal:  Epilepsia       Date:  1998-03       Impact factor: 5.864

6.  Posterior reversible encephalopathy syndrome in the Intensive Care Unit after liver transplant: a comparison of our experience with the existing literature.

Authors:  N Lunardi; E Saraceni; P Boccagni; M Segato; A Bortolato; R Manara; S Rossi; C Ori
Journal:  Minerva Anestesiol       Date:  2011-06-23       Impact factor: 3.051

Review 7.  Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment.

Authors:  R C S Seet; A A Rabinstein
Journal:  QJM       Date:  2011-08-24

8.  Cerebrovascular consequences of hypertension.

Authors:  S Strandgaard; O B Paulson
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

9.  Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer.

Authors:  Jeffrey A Allen; Ashish Adlakha; Peter R Bergethon
Journal:  Arch Neurol       Date:  2006-10

10.  Reversible posterior leukoencephalopathy syndrome after treatment of diffuse large B-cell lymphoma.

Authors:  Mark D Haefner; R Daniele Siciliano; Lucas A Widmer; Barbara M Vogel Wigger; Sonia Frick
Journal:  Onkologie       Date:  2007-02-02
View more
  6 in total

1.  Sinking skin flap syndrome in glioblastoma.

Authors:  Carlos Kamiya-Matsuoka; Sheetal Shroff; Claudio E Tatsui; Ivo W Tremont-Lukats; Mark R Gilbert
Journal:  BMJ Case Rep       Date:  2014-11-14

2.  Primary brain tumors and posterior reversible encephalopathy syndrome.

Authors:  Carlos Kamiya-Matsuoka; David Cachia; Adriana Olar; Terri S Armstrong; Mark R Gilbert
Journal:  Neurooncol Pract       Date:  2014-09-14

3.  The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus.

Authors:  Amritha Budhoo; Girish M Mody
Journal:  Clin Rheumatol       Date:  2015-08-23       Impact factor: 2.980

4.  Different Clinicoradiological Characteristics of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncology and Post-Bone Marrow Transplantation Cases: A Retrospective Study.

Authors:  Hwazen Shash; Saad Aldaama; Hala Omer; Sameera Alafghani
Journal:  Front Neurol       Date:  2022-05-06       Impact factor: 4.086

5.  Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement.

Authors:  Vincenzo Di Stefano; Marianna Gabriella Rispoli; Marco Onofrj; Maria Vittoria De Angelis
Journal:  BMJ Case Rep       Date:  2020-01-08

6.  Panitumumab-Associated Encephalopathy after Accidental Intra-arterial Application through Dislocated Central Venous Access Device.

Authors:  Slaven Pikija; Georg Pilz; Gerald Gschwandtner; Cornelia Rösler; Konstantin Schlick; Richard Greil; Johann Sellner
Journal:  Front Neurol       Date:  2016-11-07       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.